The choice of antibacterial drugs.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002439:Cefotaxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D004342:Drug Hypersensitivity / Q000209:etiology; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D016983:Enterococcus / Q000187:drug effects; D004917:Erythromycin / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016920:Meningitis, Bacterial / Q000188:drug therapy; D009503:Neutropenia / Q000188:drug therapy; D010406:Penicillins / Q000009:adverse effects; D011019:Pneumonia, Mycoplasma / Q000188:drug therapy; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D018746:Systemic Inflammatory Response Syndrome / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D004917:Erythromycin; D002439:Cefotaxime